The ROE (Return on Equity) of Talaris Therapeutics Inc (TALS) is -41.04%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2022-12-31 | -41.04% |
| 2021-12-31 | -19.70% |
| 2020-12-31 | -15.34% |
| 2019-12-31 | -45.86% |